Medical Care
Hematopoietic Stem Cells (HSCs) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 549632
- Pages: 107
- Figures: 188
- Views: 2
The global market for Hematopoietic Stem Cells (HSCs) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hematopoietic Stem Cells (HSCs) by region & country, by Type, and by Application.
The Hematopoietic Stem Cells (HSCs) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs).
Market Segmentation
By Company
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Segment by Type:
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Segment by Application
Blood System Diseases
Autoimmune Diseases
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hematopoietic Stem Cells (HSCs) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hematopoietic Stem Cells (HSCs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hematopoietic Stem Cells (HSCs) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hematopoietic Stem Cells (HSCs) by region & country, by Type, and by Application.
The Hematopoietic Stem Cells (HSCs) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs).
Market Segmentation
By Company
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Segment by Type:
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Segment by Application
Blood System Diseases
Autoimmune Diseases
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hematopoietic Stem Cells (HSCs) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hematopoietic Stem Cells (HSCs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hematopoietic Stem Cells (HSCs) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Hematopoietic Stem Cells (HSCs) Product Introduction
1.2 Global Hematopoietic Stem Cells (HSCs) Market Size Forecast
1.3 Hematopoietic Stem Cells (HSCs) Market Trends & Drivers
1.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends
1.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers & Opportunity
1.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges
1.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hematopoietic Stem Cells (HSCs) Players Revenue Ranking (2023)
2.2 Global Hematopoietic Stem Cells (HSCs) Revenue by Company (2019-2024)
2.3 Key Companies Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hematopoietic Stem Cells (HSCs) Product Offered
2.5 Key Companies Time to Begin Mass Production of Hematopoietic Stem Cells (HSCs)
2.6 Hematopoietic Stem Cells (HSCs) Market Competitive Analysis
2.6.1 Hematopoietic Stem Cells (HSCs) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Leukocyte
3.1.2 Lymphocytes
3.1.3 Red Blood Cells
3.1.4 Platelets
3.2 Global Hematopoietic Stem Cells (HSCs) Sales Value by Type
3.2.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Type (2019-2030)
3.2.3 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood System Diseases
4.1.2 Autoimmune Diseases
4.1.3 Other
4.2 Global Hematopoietic Stem Cells (HSCs) Sales Value by Application
4.2.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Application (2019-2030)
4.2.3 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region
5.1.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2019-2024)
5.1.3 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2025-2030)
5.1.4 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.2.2 North America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.3.2 Europe Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.4.2 Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.5.2 South America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.6.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value
6.3 United States
6.3.1 United States Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.3.2 United States Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.4.2 Europe Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.5.2 China Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.6.2 Japan Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.7.2 South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.8.2 Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.9.2 India Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Kite Pharma Inc.
7.1.1 Kite Pharma Inc. Profile
7.1.2 Kite Pharma Inc. Main Business
7.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.1.5 Kite Pharma Inc. Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 PromoCell
7.3.1 PromoCell Profile
7.3.2 PromoCell Main Business
7.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.3.5 CellGenix Technologie Transfer GmbH Recent Developments
7.4 CellGenix Technologie Transfer GmbH
7.4.1 CellGenix Technologie Transfer GmbH Profile
7.4.2 CellGenix Technologie Transfer GmbH Main Business
7.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.4.5 CellGenix Technologie Transfer GmbH Recent Developments
7.5 Cesca Therapeutics Inc.
7.5.1 Cesca Therapeutics Inc. Profile
7.5.2 Cesca Therapeutics Inc. Main Business
7.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.5.5 Cesca Therapeutics Inc. Recent Developments
7.6 R&D Systems
7.6.1 R&D Systems Profile
7.6.2 R&D Systems Main Business
7.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.6.5 R&D Systems Recent Developments
7.7 Genlantis
7.7.1 Genlantis Profile
7.7.2 Genlantis Main Business
7.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.7.5 Genlantis Recent Developments
7.8 Lonza Group Ltd.
7.8.1 Lonza Group Ltd. Profile
7.8.2 Lonza Group Ltd. Main Business
7.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.8.5 Lonza Group Ltd. Recent Developments
7.9 TiGenix N.V.
7.9.1 TiGenix N.V. Profile
7.9.2 TiGenix N.V. Main Business
7.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.9.5 TiGenix N.V. Recent Developments
7.10 ScienCell Research Laboratories
7.10.1 ScienCell Research Laboratories Profile
7.10.2 ScienCell Research Laboratories Main Business
7.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.10.5 ScienCell Research Laboratories Recent Developments
7.11 China Cord Blood Corporation
7.11.1 China Cord Blood Corporation Profile
7.11.2 China Cord Blood Corporation Main Business
7.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.11.5 China Cord Blood Corporation Recent Developments
7.12 Vcanbio
7.12.1 Vcanbio Profile
7.12.2 Vcanbio Main Business
7.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.12.5 Vcanbio Recent Developments
7.13 Boyalife
7.13.1 Boyalife Profile
7.13.2 Boyalife Main Business
7.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.13.5 Boyalife Recent Developments
7.14 Beike Biotechnology
7.14.1 Beike Biotechnology Profile
7.14.2 Beike Biotechnology Main Business
7.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.14.5 Beike Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Hematopoietic Stem Cells (HSCs) Industrial Chain
8.2 Hematopoietic Stem Cells (HSCs) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hematopoietic Stem Cells (HSCs) Sales Model
8.5.2 Sales Channel
8.5.3 Hematopoietic Stem Cells (HSCs) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Hematopoietic Stem Cells (HSCs) Product Introduction
1.2 Global Hematopoietic Stem Cells (HSCs) Market Size Forecast
1.3 Hematopoietic Stem Cells (HSCs) Market Trends & Drivers
1.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends
1.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers & Opportunity
1.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges
1.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hematopoietic Stem Cells (HSCs) Players Revenue Ranking (2023)
2.2 Global Hematopoietic Stem Cells (HSCs) Revenue by Company (2019-2024)
2.3 Key Companies Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hematopoietic Stem Cells (HSCs) Product Offered
2.5 Key Companies Time to Begin Mass Production of Hematopoietic Stem Cells (HSCs)
2.6 Hematopoietic Stem Cells (HSCs) Market Competitive Analysis
2.6.1 Hematopoietic Stem Cells (HSCs) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Leukocyte
3.1.2 Lymphocytes
3.1.3 Red Blood Cells
3.1.4 Platelets
3.2 Global Hematopoietic Stem Cells (HSCs) Sales Value by Type
3.2.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Type (2019-2030)
3.2.3 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood System Diseases
4.1.2 Autoimmune Diseases
4.1.3 Other
4.2 Global Hematopoietic Stem Cells (HSCs) Sales Value by Application
4.2.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Application (2019-2030)
4.2.3 Global Hematopoietic Stem Cells (HSCs) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region
5.1.1 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2019-2024)
5.1.3 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2025-2030)
5.1.4 Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.2.2 North America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.3.2 Europe Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.4.2 Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.5.2 South America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
5.6.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value
6.3 United States
6.3.1 United States Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.3.2 United States Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.4.2 Europe Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.5.2 China Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.6.2 Japan Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.7.2 South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.8.2 Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hematopoietic Stem Cells (HSCs) Sales Value, 2019-2030
6.9.2 India Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hematopoietic Stem Cells (HSCs) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Kite Pharma Inc.
7.1.1 Kite Pharma Inc. Profile
7.1.2 Kite Pharma Inc. Main Business
7.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.1.5 Kite Pharma Inc. Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 PromoCell
7.3.1 PromoCell Profile
7.3.2 PromoCell Main Business
7.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.3.5 CellGenix Technologie Transfer GmbH Recent Developments
7.4 CellGenix Technologie Transfer GmbH
7.4.1 CellGenix Technologie Transfer GmbH Profile
7.4.2 CellGenix Technologie Transfer GmbH Main Business
7.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.4.5 CellGenix Technologie Transfer GmbH Recent Developments
7.5 Cesca Therapeutics Inc.
7.5.1 Cesca Therapeutics Inc. Profile
7.5.2 Cesca Therapeutics Inc. Main Business
7.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.5.5 Cesca Therapeutics Inc. Recent Developments
7.6 R&D Systems
7.6.1 R&D Systems Profile
7.6.2 R&D Systems Main Business
7.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.6.5 R&D Systems Recent Developments
7.7 Genlantis
7.7.1 Genlantis Profile
7.7.2 Genlantis Main Business
7.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.7.5 Genlantis Recent Developments
7.8 Lonza Group Ltd.
7.8.1 Lonza Group Ltd. Profile
7.8.2 Lonza Group Ltd. Main Business
7.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.8.5 Lonza Group Ltd. Recent Developments
7.9 TiGenix N.V.
7.9.1 TiGenix N.V. Profile
7.9.2 TiGenix N.V. Main Business
7.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.9.5 TiGenix N.V. Recent Developments
7.10 ScienCell Research Laboratories
7.10.1 ScienCell Research Laboratories Profile
7.10.2 ScienCell Research Laboratories Main Business
7.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.10.5 ScienCell Research Laboratories Recent Developments
7.11 China Cord Blood Corporation
7.11.1 China Cord Blood Corporation Profile
7.11.2 China Cord Blood Corporation Main Business
7.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.11.5 China Cord Blood Corporation Recent Developments
7.12 Vcanbio
7.12.1 Vcanbio Profile
7.12.2 Vcanbio Main Business
7.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.12.5 Vcanbio Recent Developments
7.13 Boyalife
7.13.1 Boyalife Profile
7.13.2 Boyalife Main Business
7.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.13.5 Boyalife Recent Developments
7.14 Beike Biotechnology
7.14.1 Beike Biotechnology Profile
7.14.2 Beike Biotechnology Main Business
7.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
7.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue (US$ Million) & (2019-2024)
7.14.5 Beike Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Hematopoietic Stem Cells (HSCs) Industrial Chain
8.2 Hematopoietic Stem Cells (HSCs) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hematopoietic Stem Cells (HSCs) Sales Model
8.5.2 Sales Channel
8.5.3 Hematopoietic Stem Cells (HSCs) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hematopoietic Stem Cells (HSCs) Market Trends
Table 2. Hematopoietic Stem Cells (HSCs) Market Drivers & Opportunity
Table 3. Hematopoietic Stem Cells (HSCs) Market Challenges
Table 4. Hematopoietic Stem Cells (HSCs) Market Restraints
Table 5. Global Hematopoietic Stem Cells (HSCs) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hematopoietic Stem Cells (HSCs) Product Type
Table 9. Key Companies Time to Begin Mass Production of Hematopoietic Stem Cells (HSCs)
Table 10. Global Hematopoietic Stem Cells (HSCs) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2019-2024) & (%)
Table 27. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value, (2025-2030) & (US$ Million)
Table 31. Kite Pharma Inc. Basic Information List
Table 32. Kite Pharma Inc. Description and Business Overview
Table 33. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Kite Pharma Inc. (2019-2024)
Table 35. Kite Pharma Inc. Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Thermo Fisher Scientific (2019-2024)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. PromoCell Basic Information List
Table 42. PromoCell Description and Business Overview
Table 43. PromoCell Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of PromoCell (2019-2024)
Table 45. PromoCell Recent Developments
Table 46. CellGenix Technologie Transfer GmbH Basic Information List
Table 47. CellGenix Technologie Transfer GmbH Description and Business Overview
Table 48. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of CellGenix Technologie Transfer GmbH (2019-2024)
Table 50. CellGenix Technologie Transfer GmbH Recent Developments
Table 51. Cesca Therapeutics Inc. Basic Information List
Table 52. Cesca Therapeutics Inc. Description and Business Overview
Table 53. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Cesca Therapeutics Inc. (2019-2024)
Table 55. Cesca Therapeutics Inc. Recent Developments
Table 56. R&D Systems Basic Information List
Table 57. R&D Systems Description and Business Overview
Table 58. R&D Systems Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of R&D Systems (2019-2024)
Table 60. R&D Systems Recent Developments
Table 61. Genlantis Basic Information List
Table 62. Genlantis Description and Business Overview
Table 63. Genlantis Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Genlantis (2019-2024)
Table 65. Genlantis Recent Developments
Table 66. Lonza Group Ltd. Basic Information List
Table 67. Lonza Group Ltd. Description and Business Overview
Table 68. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Lonza Group Ltd. (2019-2024)
Table 70. Lonza Group Ltd. Recent Developments
Table 71. TiGenix N.V. Basic Information List
Table 72. TiGenix N.V. Description and Business Overview
Table 73. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of TiGenix N.V. (2019-2024)
Table 75. TiGenix N.V. Recent Developments
Table 76. ScienCell Research Laboratories Basic Information List
Table 77. ScienCell Research Laboratories Description and Business Overview
Table 78. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of ScienCell Research Laboratories (2019-2024)
Table 80. ScienCell Research Laboratories Recent Developments
Table 81. China Cord Blood Corporation Basic Information List
Table 82. China Cord Blood Corporation Description and Business Overview
Table 83. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of China Cord Blood Corporation (2019-2024)
Table 85. China Cord Blood Corporation Recent Developments
Table 86. Vcanbio Basic Information List
Table 87. Vcanbio Description and Business Overview
Table 88. Vcanbio Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Vcanbio (2019-2024)
Table 90. Vcanbio Recent Developments
Table 91. Boyalife Basic Information List
Table 92. Boyalife Description and Business Overview
Table 93. Boyalife Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Boyalife (2019-2024)
Table 95. Boyalife Recent Developments
Table 96. Beike Biotechnology Basic Information List
Table 97. Beike Biotechnology Description and Business Overview
Table 98. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 99. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Beike Biotechnology (2019-2024)
Table 100. Beike Biotechnology Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Hematopoietic Stem Cells (HSCs) Downstream Customers
Table 104. Hematopoietic Stem Cells (HSCs) Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hematopoietic Stem Cells (HSCs) Product Picture
Figure 2. Global Hematopoietic Stem Cells (HSCs) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 4. Hematopoietic Stem Cells (HSCs) Report Years Considered
Figure 5. Global Hematopoietic Stem Cells (HSCs) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2023
Figure 7. Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Leukocyte Picture
Figure 9. Lymphocytes Picture
Figure 10. Red Blood Cells Picture
Figure 11. Platelets Picture
Figure 12. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Hematopoietic Stem Cells (HSCs) Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Blood System Diseases
Figure 15. Product Picture of Autoimmune Diseases
Figure 16. Product Picture of Other
Figure 17. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Hematopoietic Stem Cells (HSCs) Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value (%), (2019-2030)
Figure 30. United States Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 36. China Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 38. China Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 48. India Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 50. India Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 51. Hematopoietic Stem Cells (HSCs) Industrial Chain
Figure 52. Hematopoietic Stem Cells (HSCs) Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Hematopoietic Stem Cells (HSCs) Market Trends
Table 2. Hematopoietic Stem Cells (HSCs) Market Drivers & Opportunity
Table 3. Hematopoietic Stem Cells (HSCs) Market Challenges
Table 4. Hematopoietic Stem Cells (HSCs) Market Restraints
Table 5. Global Hematopoietic Stem Cells (HSCs) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hematopoietic Stem Cells (HSCs) Product Type
Table 9. Key Companies Time to Begin Mass Production of Hematopoietic Stem Cells (HSCs)
Table 10. Global Hematopoietic Stem Cells (HSCs) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hematopoietic Stem Cells (HSCs) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2019-2024) & (%)
Table 27. Global Hematopoietic Stem Cells (HSCs) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value, (2025-2030) & (US$ Million)
Table 31. Kite Pharma Inc. Basic Information List
Table 32. Kite Pharma Inc. Description and Business Overview
Table 33. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Kite Pharma Inc. (2019-2024)
Table 35. Kite Pharma Inc. Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Thermo Fisher Scientific (2019-2024)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. PromoCell Basic Information List
Table 42. PromoCell Description and Business Overview
Table 43. PromoCell Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of PromoCell (2019-2024)
Table 45. PromoCell Recent Developments
Table 46. CellGenix Technologie Transfer GmbH Basic Information List
Table 47. CellGenix Technologie Transfer GmbH Description and Business Overview
Table 48. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of CellGenix Technologie Transfer GmbH (2019-2024)
Table 50. CellGenix Technologie Transfer GmbH Recent Developments
Table 51. Cesca Therapeutics Inc. Basic Information List
Table 52. Cesca Therapeutics Inc. Description and Business Overview
Table 53. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Cesca Therapeutics Inc. (2019-2024)
Table 55. Cesca Therapeutics Inc. Recent Developments
Table 56. R&D Systems Basic Information List
Table 57. R&D Systems Description and Business Overview
Table 58. R&D Systems Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of R&D Systems (2019-2024)
Table 60. R&D Systems Recent Developments
Table 61. Genlantis Basic Information List
Table 62. Genlantis Description and Business Overview
Table 63. Genlantis Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Genlantis (2019-2024)
Table 65. Genlantis Recent Developments
Table 66. Lonza Group Ltd. Basic Information List
Table 67. Lonza Group Ltd. Description and Business Overview
Table 68. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Lonza Group Ltd. (2019-2024)
Table 70. Lonza Group Ltd. Recent Developments
Table 71. TiGenix N.V. Basic Information List
Table 72. TiGenix N.V. Description and Business Overview
Table 73. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of TiGenix N.V. (2019-2024)
Table 75. TiGenix N.V. Recent Developments
Table 76. ScienCell Research Laboratories Basic Information List
Table 77. ScienCell Research Laboratories Description and Business Overview
Table 78. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of ScienCell Research Laboratories (2019-2024)
Table 80. ScienCell Research Laboratories Recent Developments
Table 81. China Cord Blood Corporation Basic Information List
Table 82. China Cord Blood Corporation Description and Business Overview
Table 83. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of China Cord Blood Corporation (2019-2024)
Table 85. China Cord Blood Corporation Recent Developments
Table 86. Vcanbio Basic Information List
Table 87. Vcanbio Description and Business Overview
Table 88. Vcanbio Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Vcanbio (2019-2024)
Table 90. Vcanbio Recent Developments
Table 91. Boyalife Basic Information List
Table 92. Boyalife Description and Business Overview
Table 93. Boyalife Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Boyalife (2019-2024)
Table 95. Boyalife Recent Developments
Table 96. Beike Biotechnology Basic Information List
Table 97. Beike Biotechnology Description and Business Overview
Table 98. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Products, Services and Solutions
Table 99. Revenue (US$ Million) in Hematopoietic Stem Cells (HSCs) Business of Beike Biotechnology (2019-2024)
Table 100. Beike Biotechnology Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Hematopoietic Stem Cells (HSCs) Downstream Customers
Table 104. Hematopoietic Stem Cells (HSCs) Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hematopoietic Stem Cells (HSCs) Product Picture
Figure 2. Global Hematopoietic Stem Cells (HSCs) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 4. Hematopoietic Stem Cells (HSCs) Report Years Considered
Figure 5. Global Hematopoietic Stem Cells (HSCs) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2023
Figure 7. Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Leukocyte Picture
Figure 9. Lymphocytes Picture
Figure 10. Red Blood Cells Picture
Figure 11. Platelets Picture
Figure 12. Global Hematopoietic Stem Cells (HSCs) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Hematopoietic Stem Cells (HSCs) Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Blood System Diseases
Figure 15. Product Picture of Autoimmune Diseases
Figure 16. Product Picture of Other
Figure 17. Global Hematopoietic Stem Cells (HSCs) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Hematopoietic Stem Cells (HSCs) Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Hematopoietic Stem Cells (HSCs) Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Hematopoietic Stem Cells (HSCs) Sales Value (%), (2019-2030)
Figure 30. United States Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 36. China Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 38. China Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 48. India Hematopoietic Stem Cells (HSCs) Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Hematopoietic Stem Cells (HSCs) Sales Value by Type (%), 2023 VS 2030
Figure 50. India Hematopoietic Stem Cells (HSCs) Sales Value by Application (%), 2023 VS 2030
Figure 51. Hematopoietic Stem Cells (HSCs) Industrial Chain
Figure 52. Hematopoietic Stem Cells (HSCs) Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232